newsfilter
← Latest News
Business Wire·

Repare Therapeutics Provides Corporate Update and Highlights Anticipated Key 2024 Milestones

Repare Therapeutics Inc. ("Repare" or the "Company") (NASDAQ:RPTX), a leading clinical-stage precision oncology company, today provided a corporate update and highlighted key milestones anticipated in 2024. "We